SCHEMBL6920663

SCHEMBL6920663

COC(OC)c1ccc(C(=O)O)o1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
HPGD P15428 6/20 0.45
TDP1 Q9NUW8 4/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 2/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17582660 0.82 MEN1 (0.56) ALDH1A1HPGDKDM4EMAPTMEN1
SCHEMBL5520513 0.77 TDP1 (0.47) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL10984187 0.77 TDP1 (0.47) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL7138575 0.75 ALDH1A1 (0.65) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL22823036 0.75 TDP1 (0.45) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL28289835 0.75 TDP1 (0.45) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL28582917 0.74 MEN1 (0.51) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL19873092 0.74 TDP1 (0.48) ALDH1A1HPGDTDP1KDM4EHSD17B10
SCHEMBL27262022 0.73 TDP1 (0.44) ALDH1A1HPGDTDP1KDM4EHSD17B10
Hydrochloric Acid SCHEMBL31462928 0.73 ALDH1A1 (0.63) ALDH1A1HPGDTDP1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11603360-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate EASTMAN CHEMICAL COMPANY (US) 2023-03-14 US claimed
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2020-10-22 US claimed
US-10696645-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate EASTMAN CHEMICAL COMPANY (US) 2020-06-30 US claimed
US-20190023676-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2019-01-24 US claimed
US-11603360-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate EASTMAN CHEMICAL COMPANY (US) 2023-03-14 US disclosed
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2020-10-22 US disclosed
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2020-10-22 US disclosed
US-10696645-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate EASTMAN CHEMICAL COMPANY (US) 2020-06-30 US disclosed
US-10696645-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate EASTMAN CHEMICAL COMPANY (US) 2020-06-30 US disclosed
US-20190023675-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2019-01-24 US disclosed
US-20190023676-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2019-01-24 US disclosed
US-20190023675-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2019-01-24 US disclosed
US-20190023676-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2019-01-24 US disclosed
CN-107954959-A Method for preparing 2, 5-furandicarboxylic acid and precursor substance thereof 南京工业大学 2018-04-24 CN disclosed
WO-2004037808-A1 2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2004-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE DDC, ACACA, ACACB ALDH1A1 198/4885HPGD 2287/4885TDP1 2646/4885
US-10696645-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate DDC, ACACA, ACACB ALDH1A1 198/4885HPGD 2287/4885TDP1 2646/4885
US-20190023675-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE DDC, ACACA, ACACB ALDH1A1 198/4885HPGD 2287/4885TDP1 2646/4885
US-20190023676-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE DDC, ACACA, ACACB ALDH1A1 198/4885HPGD 2287/4885TDP1 2646/4885
US-11603360-B2 Method for producing purified dialkyl-furan-2,5-dicarboxylate DDC, ACACA, ACACB ALDH1A1 198/4885HPGD 2287/4885TDP1 2646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.